# Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults

> **NCT02017405** · NA · COMPLETED · sponsor: **Entera Health, Inc** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Serum-derived bovine immunoglobulin protein isolate (SBI)
- **OTHER:** Matching Placebo

## Key facts

- **NCT ID:** NCT02017405
- **Lead sponsor:** Entera Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017405, "Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02017405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*